Boston Scientific Corp (BSX) Stock Rose While Jana Partners LLC Trimmed Its Holding by $50.78 Million

Boston Scientific Corporation (NYSE:BSX) LogoInvestors sentiment increased to 1.2 in 2018 Q2. Its up 0.24, from 0.96 in 2018Q1. It improved, as 38 investors sold BSX shares while 177 reduced holdings. 92 funds opened positions while 167 raised stakes. 1.21 billion shares or 2.60% more from 1.18 billion shares in 2018Q1 were reported. Alphamark Advisors Lc holds 350 shares. Cambridge Inv Advsr has invested 0.01% in Boston Scientific Corporation (NYSE:BSX). Sectoral Asset Mngmt owns 189,900 shares or 0.69% of their US portfolio. Teachers Retirement Sys Of The State Of Kentucky holds 0.37% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 954,265 shares. Moreover, Asset Mgmt One Communications Limited has 0.16% invested in Boston Scientific Corporation (NYSE:BSX) for 2.24M shares. Comerica Fincl Bank invested 0.09% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Jana Partners has invested 2.72% in Boston Scientific Corporation (NYSE:BSX). Huntington Bankshares holds 0.01% or 20,252 shares in its portfolio. Valley Advisers invested 0% in Boston Scientific Corporation (NYSE:BSX). The Maryland-based Profund Advsr Ltd Limited Liability Company has invested 0.06% in Boston Scientific Corporation (NYSE:BSX). Invesco Limited holds 8.28M shares or 0.09% of its portfolio. Fmr Limited has 156.62 million shares. Cornerstone Advsrs Inc invested 0.25% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Tudor Invest Corporation Et Al owns 30,623 shares for 0.03% of their portfolio. Orbimed Advisors Ltd Liability Co holds 3.73% or 9.57 million shares in its portfolio.

Since June 7, 2018, it had 0 buys, and 20 sales for $20.51 million activity. Shares for $879,886 were sold by Thepaut Eric Francis Yves on Friday, November 9. FUJIMORI YOSHIAKI also sold $228,090 worth of Boston Scientific Corporation (NYSE:BSX) on Friday, November 30. Sununu John E had sold 72 shares worth $2,511 on Wednesday, August 15. The insider Mirviss Jeffrey B. sold 19,323 shares worth $630,703. Shares for $54,965 were sold by Carruthers Wendy on Friday, November 2. Sorenson John Bradley sold 10,000 shares worth $358,607.

Jana Partners Llc decreased its stake in Boston Scientific Corp (BSX) by 33.59% based on its latest 2018Q2 regulatory filing with the SEC. Jana Partners Llc sold 1.59 million shares as the company’s stock rose 14.84% with the market. The hedge fund held 3.14 million shares of the medical and dental instruments company at the end of 2018Q2, valued at $102.60 million, down from 4.72M at the end of the previous reported quarter. Jana Partners Llc who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $49.10 billion market cap company. The stock decreased 3.51% or $1.29 during the last trading session, reaching $35.48. About 7.40 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 25.61% since December 8, 2017 and is uptrending. It has outperformed by 9.99% the S&P500.

Jana Partners Llc, which manages about $11.37B and $3.78B US Long portfolio, upped its stake in Dr Pepper Snapple Group Inc (Call) (NYSE:DPS) by 1.71M shares to 2.30M shares, valued at $281.02M in 2018Q2, according to the filing. It also increased its holding in Tiffany & Co New (NYSE:TIF) by 1.69 million shares in the quarter, for a total of 1.76 million shares, and has risen its stake in Spdr S&P 500 Etf Tr (SPY).

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 7. They expect $0.37 EPS, up 8.82 % or $0.03 from last year’s $0.34 per share. BSX’s profit will be $512.00 million for 23.97 P/E if the $0.37 EPS becomes a reality. After $0.35 actual EPS reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 5.71 % EPS growth.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Bizjournals.com which released: “Boston Scientific to buy British medical device firm for $4.2B – Boston Business Journal” on November 20, 2018, also Benzinga.com with their article: “26 Stocks Moving In Tuesday’s Pre-Market Session – Benzinga” published on November 20, 2018, 247Wallst.com published: “Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, CME, DaVita, Skyworks, Spirit Air, AMD, Nvidia and More – 24/7 Wall St.” on November 28, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: Seekingalpha.com and their article: “Boston Scientific Corporation (BSX) Management on Citi’s 2018 Global Healthcare Conference Call (Transcript) – Seeking Alpha” published on December 06, 2018 as well as Benzinga.com‘s news article titled: “Jim Cramer Gives His Opinion On Boston Scientific, MongoDB And More – Benzinga” with publication date: November 28, 2018.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

Among 10 analysts covering Boston Scientific Corp (NYSE:BSX), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Boston Scientific Corp had 11 analyst reports since June 12, 2018 according to SRatingsIntel. Canaccord Genuity maintained it with “Buy” rating and $42 target in Thursday, October 25 report. The firm has “Buy” rating given on Friday, October 26 by Argus Research. On Monday, September 17 the stock rating was maintained by Wells Fargo with “Outperform”. Raymond James maintained the shares of BSX in report on Tuesday, September 4 with “Strong Buy” rating. On Tuesday, September 4 the stock rating was upgraded by Jefferies to “Buy”. As per Tuesday, October 2, the company rating was maintained by Morgan Stanley. Morgan Stanley maintained it with “Overweight” rating and $38 target in Thursday, July 26 report.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.